Portfolio Holdings Detail for ISIN IE00BL3J3G74
Stock Name / Fund iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CSPXx(MXN) CXE

Holdings detail for LLY

Stock Name	Eli Lilly and Company
Ticker	LLY(EUR) F
TYPE	Common Stock
Country	Germany
ISIN	US5324571083
LEI	FRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG: Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs: With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About: Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price: Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial: (RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY: The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today: Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock: Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years: Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever: Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years: Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?: Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!: My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks: In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?: Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies: Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats: Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble: Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years: Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade: Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way: Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly: In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis: Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.: Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now: Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks: Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?: Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy: In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares Core S&P 500 UCITS ETF MXN Hedged (Acc) LLY holdings

Date	Number of LLY Shares Held	Base Market Value of LLY Shares	Local Market Value of LLY Shares	Change in LLY Shares Held	Change in LLY Base Value	Current Price per LLY Share Held	Previous Price per LLY Share Held
2025-09-18 (Thursday)	1,858,365	USD 1,417,802,409	USD 1,417,802,409	109	USD 5,286,276	USD 762.93	USD 760.13
2025-09-17 (Wednesday)	1,858,256	USD 1,412,516,133	USD 1,412,516,133	981	USD -7,760,632	USD 760.13	USD 764.71
2025-09-16 (Tuesday)	1,857,275	USD 1,420,276,765	USD 1,420,276,765
2025-09-15 (Monday)	1,856,839	USD 1,389,268,371	USD 1,389,268,371
2025-09-12 (Friday)	1,855,749	USD 1,401,814,237	USD 1,401,814,237
2025-09-11 (Thursday)	1,855,422	USD 1,403,218,550	USD 1,403,218,550	545	USD 3,491,268	USD 756.28	USD 754.62
2025-09-10 (Wednesday)	1,854,877	USD 1,399,727,282	USD 1,399,727,282	0	USD 7,438,057	USD 754.62	USD 750.61
2025-09-09 (Tuesday)	1,854,877	USD 1,392,289,225	USD 1,392,289,225	545	USD 22,605,437	USD 750.61	USD 738.64

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00BL3J3G74

Show aggregate share trades of LLY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-18 BUY 109 762.930* 806.74
2025-09-17 BUY 981 760.130* 807.00
2025-09-11 BUY 545 756.280* 807.30
2025-09-09 BUY 545 750.610* 807.94
2025-07-31 SELL -1,826 740.070* 808.34 Profit of 1,476,021 on sale
2025-07-30 BUY 872 760.080* 808.62
2025-07-29 BUY 109 762.950* 808.89
2025-07-24 BUY 109 805.430* 808.91
2025-07-23 BUY 654 798.890* 808.97
2025-07-22 BUY 981 776.440* 809.17
2025-07-21 BUY 218 762.180* 809.46
2025-07-18 SELL -1,091 771.710* 809.69 Profit of 883,372 on sale
2025-07-17 BUY 109 761.500* 809.99
2025-07-16 BUY 436 789.800* 810.11
2025-07-15 SELL -1,665 771.750* 810.35 Profit of 1,349,237 on sale
2025-07-14 BUY 872 799.340* 810.42
2025-07-11 SELL -218 793.010* 810.53 Profit of 176,696 on sale
2025-07-10 BUY 872 790.650* 810.66
2025-07-09 BUY 872 786.920* 810.81
2025-07-08 BUY 656 777.660* 811.02
2025-07-07 SELL -2,507 772.870* 811.27 Profit of 2,033,860 on sale
2025-07-02 SELL -3,161 779.280* 811.89 Profit of 2,566,383 on sale
2025-06-30 BUY 1,853 779.530* 812.11
2025-06-27 BUY 981 775.450* 812.35
2025-06-25 SELL -218 792.300* 812.60 Profit of 177,148 on sale
2025-06-24 BUY 113 778.080* 812.84
2025-06-23 BUY 2,834 770.640* 813.13
2025-06-18 SELL -654 785.030* 813.53 Profit of 532,046 on sale
2025-06-13 SELL -327 819.360* 813.69 Profit of 266,075 on sale
2025-06-12 BUY 327 812.030* 813.70
2025-06-11 BUY 436 808.610* 813.73
2025-06-06 SELL -545 769.880* 814.40 Profit of 443,850 on sale
2025-06-05 SELL -327 765.680* 814.77 Profit of 266,429 on sale
2025-06-04 SELL -436 765.840* 815.14 Profit of 355,399 on sale
2025-06-02 BUY 1,417 747.120* 816.15
2025-05-30 SELL -315 737.670* 816.75 Profit of 257,276 on sale
2025-05-29 BUY 109 722.570* 817.48
2025-05-28 SELL -109 719.390* 818.25 Profit of 89,189 on sale
2025-05-27 BUY 1,199 725.220* 818.98
2025-05-23 SELL -2,180 713.710* 820.66 Profit of 1,789,045 on sale
2025-05-22 SELL -2,398 715.200* 821.51 Profit of 1,969,989 on sale
2025-05-21 BUY 109 724.950* 822.30
2025-05-20 BUY 872 747.010* 822.92
2025-05-19 BUY 3,161 755.110* 823.48
2025-05-16 BUY 2,943 757.390* 824.03
2025-05-15 BUY 2,398 733.290* 824.79
2025-05-14 BUY 2,180 715.560* 825.71
2025-05-13 SELL -436 746.060* 826.40 Profit of 360,308 on sale
2025-05-12 BUY 109 755.570* 827.01
2025-05-09 BUY 327 734.570* 827.81
2025-05-08 SELL -3,161 751.450* 828.48 Profit of 2,618,824 on sale
2025-05-07 SELL -1,526 776.720* 828.94 Profit of 1,264,959 on sale
2025-05-06 BUY 3,815 775.120* 829.42
2025-05-02 BUY 327 823.620* 829.54
2025-05-01 SELL -545 794.100* 829.87 Profit of 452,278 on sale
2025-04-30 BUY 327 898.950* 829.23
2025-04-29 BUY 763 885.200* 828.71
2025-04-28 BUY 1,627 877.290* 828.25
2025-04-25 BUY 1,526 884.540* 827.71
2025-04-24 BUY 436 859.730* 827.40
2025-04-23 BUY 1,199 829.420* 827.38
2025-04-22 SELL -662 827.540* 827.38 Profit of 547,727 on sale
2025-04-17 BUY 218 839.960* 827.13
2025-04-16 BUY 3,213 734.900* 828.06
2025-04-15 BUY 2,180 757.180* 828.79
2025-04-11 BUY 2,725 732.410* 830.56
2025-04-10 BUY 4,469 720.910* 831.72
2025-04-09 BUY 872 753.710* 832.55
2025-04-08 BUY 2,289 726.240* 833.69
2025-04-07 BUY 2,612 723.730* 834.89
2025-04-04 SELL -6,540 738.210* 835.95 Profit of 5,467,112 on sale
2025-04-02 BUY 763 818.220* 836.15
2025-03-31 SELL -2,943 825.910* 836.61 Profit of 2,462,156 on sale
2025-03-28 SELL -1,853 822.510* 836.78 Profit of 1,550,547 on sale
2025-03-27 SELL -545 821.670* 836.95 Profit of 456,139 on sale
2025-03-26 BUY 981 826.760* 837.07
2025-03-25 SELL -1,308 852.350* 836.89 Profit of 1,094,652 on sale
2025-03-24 BUY 763 864.900* 836.55
2025-03-21 BUY 4,257 837.570* 836.54
2025-03-19 BUY 204 837.010* 836.46
2025-03-18 SELL -1,944 822.510* 836.64 Profit of 1,626,420 on sale
2025-03-17 BUY 2,052 824.760* 836.79
2025-03-14 BUY 1,836 813.480* 837.09
2025-03-13 BUY 9,060 801.650* 837.56
2025-03-12 BUY 4,320 821.860* 837.77
2025-03-11 BUY 1,728 824.060* 837.95
2025-03-07 BUY 1,032 869.580* 837.63
2025-03-06 SELL -972 912.760* 836.57 Profit of 813,144 on sale
2025-03-05 BUY 3,360 929.720* 835.24
2025-03-04 BUY 648 911.060* 834.14
2025-03-03 BUY 2,916 929.720* 832.73
2025-02-28 SELL -756 920.630* 831.42 Profit of 628,554 on sale
2025-02-27 BUY 108 905.160* 830.30
2025-02-26 SELL -216 915.010* 829.00 Profit of 179,064 on sale
2025-02-25 BUY 2,052 901.800* 827.86
2025-02-21 BUY 1,512 873.680* 826.26
2025-02-20 BUY 864 873.120* 825.49
2025-02-19 BUY 216 867.050* 824.80
2025-02-18 BUY 540 857.200* 824.25
2025-02-13 BUY 1,836 871.860* 822.69
2025-02-12 BUY 648 872.970* 821.77
2025-02-11 SELL -216 865.000* 820.97 Profit of 177,330 on sale
2025-02-07 SELL -864 878.310* 818.95 Profit of 707,569 on sale
2025-02-06 BUY 432 870.370* 817.94
2025-02-04 BUY 3,780 826.070* 817.28
2025-02-03 BUY 1,404 810.430* 817.42
2025-01-31 BUY 324 811.080* 817.55
2025-01-30 BUY 216 823.230* 817.43
2025-01-29 BUY 2,052 804.080* 817.73
2025-01-28 BUY 972 804.990* 818.02
2025-01-27 BUY 1,512 808.170* 818.25
2025-01-24 BUY 972 785.410* 819.03
2025-01-23 BUY 2,808 766.600* 820.31
2025-01-02 BUY 3,564 778.070* 821.36
2024-12-30 BUY 25,927 773.840* 822.58
2024-12-10 BUY 763 799.580* 823.19
2024-12-09 BUY 872 803.580* 823.72
2024-12-06 BUY 1,308 826.710* 823.63
2024-12-05 BUY 327 825.620* 823.58
2024-12-04 BUY 1,199 829.840* 823.39
2024-12-03 BUY 3,842 813.330* 823.70
2024-12-02 BUY 322 799.800* 824.44
2024-11-29 BUY 1,488 795.350* 825.38
2024-11-27 BUY 2,943 788.190* 827.95
2024-11-26 BUY 6,322 789.320* 829.33
2024-11-25 BUY 6,540 755.000* 832.08
2024-11-22 BUY 7,630 748.010* 835.31
2024-11-21 BUY 1,199 749.920* 838.73
2024-11-20 BUY 1,090 753.410* 842.28
2024-11-19 BUY 981 729.730* 847.18
2024-11-18 BUY 8,829 727.200* 852.63
2024-11-12 BUY 3,052 818.860* 854.24
2024-11-11 BUY 2,071 832.440* 855.33
2024-11-08 BUY 1,562 831.540* 856.58
2024-11-07 BUY 9,701 797.450* 859.87
2024-11-06 BUY 8,048 776.380* 864.78
2024-11-05 BUY 4,342 806.060* 872.61
2024-11-05 BUY 4,342 806.060* 872.61
2024-11-04 BUY 763 806.140* 882.83
2024-11-04 BUY 763 806.140* 882.83
2024-11-01 BUY 1,744 818.930* 888.16
2024-10-31 BUY 432 829.740* 893.47
2024-10-30 BUY 1,074 846.830* 898.13
2024-10-29 BUY 3,996 903.580* 897.53
2024-10-28 SELL -756 895.590* 898.08 Profit of 678,950 on sale
2024-10-28 SELL -756 895.590* 898.08 Profit of 678,950 on sale
2024-10-25 BUY 1,296 892.700* 900.23
2024-10-25 BUY 1,296 892.700* 900.23
2024-10-24 BUY 864 891.320* 906.18
2024-10-24 BUY 864 891.320* 906.18
2024-10-23 BUY 1,080 903.250* 907.64
2024-10-22 BUY 5,815 909.150* 906.13
2024-10-21 BUY 3,024 906.130* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-18	BUY	109	762.930*	806.74
2025-09-17	BUY	981	760.130*	807.00
2025-09-11	BUY	545	756.280*	807.30
2025-09-09	BUY	545	750.610*	807.94
2025-07-31	SELL	-1,826	740.070*	808.34 Profit of 1,476,021 on sale
2025-07-30	BUY	872	760.080*	808.62
2025-07-29	BUY	109	762.950*	808.89
2025-07-24	BUY	109	805.430*	808.91
2025-07-23	BUY	654	798.890*	808.97
2025-07-22	BUY	981	776.440*	809.17
2025-07-21	BUY	218	762.180*	809.46
2025-07-18	SELL	-1,091	771.710*	809.69 Profit of 883,372 on sale
2025-07-17	BUY	109	761.500*	809.99
2025-07-16	BUY	436	789.800*	810.11
2025-07-15	SELL	-1,665	771.750*	810.35 Profit of 1,349,237 on sale
2025-07-14	BUY	872	799.340*	810.42
2025-07-11	SELL	-218	793.010*	810.53 Profit of 176,696 on sale
2025-07-10	BUY	872	790.650*	810.66
2025-07-09	BUY	872	786.920*	810.81
2025-07-08	BUY	656	777.660*	811.02
2025-07-07	SELL	-2,507	772.870*	811.27 Profit of 2,033,860 on sale
2025-07-02	SELL	-3,161	779.280*	811.89 Profit of 2,566,383 on sale
2025-06-30	BUY	1,853	779.530*	812.11
2025-06-27	BUY	981	775.450*	812.35
2025-06-25	SELL	-218	792.300*	812.60 Profit of 177,148 on sale
2025-06-24	BUY	113	778.080*	812.84
2025-06-23	BUY	2,834	770.640*	813.13
2025-06-18	SELL	-654	785.030*	813.53 Profit of 532,046 on sale
2025-06-13	SELL	-327	819.360*	813.69 Profit of 266,075 on sale
2025-06-12	BUY	327	812.030*	813.70
2025-06-11	BUY	436	808.610*	813.73
2025-06-06	SELL	-545	769.880*	814.40 Profit of 443,850 on sale
2025-06-05	SELL	-327	765.680*	814.77 Profit of 266,429 on sale
2025-06-04	SELL	-436	765.840*	815.14 Profit of 355,399 on sale
2025-06-02	BUY	1,417	747.120*	816.15
2025-05-30	SELL	-315	737.670*	816.75 Profit of 257,276 on sale
2025-05-29	BUY	109	722.570*	817.48
2025-05-28	SELL	-109	719.390*	818.25 Profit of 89,189 on sale
2025-05-27	BUY	1,199	725.220*	818.98
2025-05-23	SELL	-2,180	713.710*	820.66 Profit of 1,789,045 on sale
2025-05-22	SELL	-2,398	715.200*	821.51 Profit of 1,969,989 on sale
2025-05-21	BUY	109	724.950*	822.30
2025-05-20	BUY	872	747.010*	822.92
2025-05-19	BUY	3,161	755.110*	823.48
2025-05-16	BUY	2,943	757.390*	824.03
2025-05-15	BUY	2,398	733.290*	824.79
2025-05-14	BUY	2,180	715.560*	825.71
2025-05-13	SELL	-436	746.060*	826.40 Profit of 360,308 on sale
2025-05-12	BUY	109	755.570*	827.01
2025-05-09	BUY	327	734.570*	827.81
2025-05-08	SELL	-3,161	751.450*	828.48 Profit of 2,618,824 on sale
2025-05-07	SELL	-1,526	776.720*	828.94 Profit of 1,264,959 on sale
2025-05-06	BUY	3,815	775.120*	829.42
2025-05-02	BUY	327	823.620*	829.54
2025-05-01	SELL	-545	794.100*	829.87 Profit of 452,278 on sale
2025-04-30	BUY	327	898.950*	829.23
2025-04-29	BUY	763	885.200*	828.71
2025-04-28	BUY	1,627	877.290*	828.25
2025-04-25	BUY	1,526	884.540*	827.71
2025-04-24	BUY	436	859.730*	827.40
2025-04-23	BUY	1,199	829.420*	827.38
2025-04-22	SELL	-662	827.540*	827.38 Profit of 547,727 on sale
2025-04-17	BUY	218	839.960*	827.13
2025-04-16	BUY	3,213	734.900*	828.06
2025-04-15	BUY	2,180	757.180*	828.79
2025-04-11	BUY	2,725	732.410*	830.56
2025-04-10	BUY	4,469	720.910*	831.72
2025-04-09	BUY	872	753.710*	832.55
2025-04-08	BUY	2,289	726.240*	833.69
2025-04-07	BUY	2,612	723.730*	834.89
2025-04-04	SELL	-6,540	738.210*	835.95 Profit of 5,467,112 on sale
2025-04-02	BUY	763	818.220*	836.15
2025-03-31	SELL	-2,943	825.910*	836.61 Profit of 2,462,156 on sale
2025-03-28	SELL	-1,853	822.510*	836.78 Profit of 1,550,547 on sale
2025-03-27	SELL	-545	821.670*	836.95 Profit of 456,139 on sale
2025-03-26	BUY	981	826.760*	837.07
2025-03-25	SELL	-1,308	852.350*	836.89 Profit of 1,094,652 on sale
2025-03-24	BUY	763	864.900*	836.55
2025-03-21	BUY	4,257	837.570*	836.54
2025-03-19	BUY	204	837.010*	836.46
2025-03-18	SELL	-1,944	822.510*	836.64 Profit of 1,626,420 on sale
2025-03-17	BUY	2,052	824.760*	836.79
2025-03-14	BUY	1,836	813.480*	837.09
2025-03-13	BUY	9,060	801.650*	837.56
2025-03-12	BUY	4,320	821.860*	837.77
2025-03-11	BUY	1,728	824.060*	837.95
2025-03-07	BUY	1,032	869.580*	837.63
2025-03-06	SELL	-972	912.760*	836.57 Profit of 813,144 on sale
2025-03-05	BUY	3,360	929.720*	835.24
2025-03-04	BUY	648	911.060*	834.14
2025-03-03	BUY	2,916	929.720*	832.73
2025-02-28	SELL	-756	920.630*	831.42 Profit of 628,554 on sale
2025-02-27	BUY	108	905.160*	830.30
2025-02-26	SELL	-216	915.010*	829.00 Profit of 179,064 on sale
2025-02-25	BUY	2,052	901.800*	827.86
2025-02-21	BUY	1,512	873.680*	826.26
2025-02-20	BUY	864	873.120*	825.49
2025-02-19	BUY	216	867.050*	824.80
2025-02-18	BUY	540	857.200*	824.25
2025-02-13	BUY	1,836	871.860*	822.69
2025-02-12	BUY	648	872.970*	821.77
2025-02-11	SELL	-216	865.000*	820.97 Profit of 177,330 on sale
2025-02-07	SELL	-864	878.310*	818.95 Profit of 707,569 on sale
2025-02-06	BUY	432	870.370*	817.94
2025-02-04	BUY	3,780	826.070*	817.28
2025-02-03	BUY	1,404	810.430*	817.42
2025-01-31	BUY	324	811.080*	817.55
2025-01-30	BUY	216	823.230*	817.43
2025-01-29	BUY	2,052	804.080*	817.73
2025-01-28	BUY	972	804.990*	818.02
2025-01-27	BUY	1,512	808.170*	818.25
2025-01-24	BUY	972	785.410*	819.03
2025-01-23	BUY	2,808	766.600*	820.31
2025-01-02	BUY	3,564	778.070*	821.36
2024-12-30	BUY	25,927	773.840*	822.58
2024-12-10	BUY	763	799.580*	823.19
2024-12-09	BUY	872	803.580*	823.72
2024-12-06	BUY	1,308	826.710*	823.63
2024-12-05	BUY	327	825.620*	823.58
2024-12-04	BUY	1,199	829.840*	823.39
2024-12-03	BUY	3,842	813.330*	823.70
2024-12-02	BUY	322	799.800*	824.44
2024-11-29	BUY	1,488	795.350*	825.38
2024-11-27	BUY	2,943	788.190*	827.95
2024-11-26	BUY	6,322	789.320*	829.33
2024-11-25	BUY	6,540	755.000*	832.08
2024-11-22	BUY	7,630	748.010*	835.31
2024-11-21	BUY	1,199	749.920*	838.73
2024-11-20	BUY	1,090	753.410*	842.28
2024-11-19	BUY	981	729.730*	847.18
2024-11-18	BUY	8,829	727.200*	852.63
2024-11-12	BUY	3,052	818.860*	854.24
2024-11-11	BUY	2,071	832.440*	855.33
2024-11-08	BUY	1,562	831.540*	856.58
2024-11-07	BUY	9,701	797.450*	859.87
2024-11-06	BUY	8,048	776.380*	864.78
2024-11-05	BUY	4,342	806.060*	872.61
2024-11-05	BUY	4,342	806.060*	872.61
2024-11-04	BUY	763	806.140*	882.83
2024-11-04	BUY	763	806.140*	882.83
2024-11-01	BUY	1,744	818.930*	888.16
2024-10-31	BUY	432	829.740*	893.47
2024-10-30	BUY	1,074	846.830*	898.13
2024-10-29	BUY	3,996	903.580*	897.53
2024-10-28	SELL	-756	895.590*	898.08 Profit of 678,950 on sale
2024-10-28	SELL	-756	895.590*	898.08 Profit of 678,950 on sale
2024-10-25	BUY	1,296	892.700*	900.23
2024-10-25	BUY	1,296	892.700*	900.23
2024-10-24	BUY	864	891.320*	906.18
2024-10-24	BUY	864	891.320*	906.18
2024-10-23	BUY	1,080	903.250*	907.64
2024-10-22	BUY	5,815	909.150*	906.13
2024-10-21	BUY	3,024	906.130*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	432,038	935	1,319,853	32.7%
2025-09-18	547,818	126	1,290,147	42.5%
2025-09-17	437,337	427	1,166,204	37.5%
2025-09-16	532,698	1,829	1,463,374	36.4%
2025-09-15	424,979	701	1,071,487	39.7%
2025-09-12	267,121	172	826,802	32.3%
2025-09-11	249,803	1,484	850,461	29.4%
2025-09-10	415,442	1,025	989,008	42.0%
2025-09-09	559,805	667	1,270,800	44.1%
2025-09-08	856,018	4,682	1,937,447	44.2%
2025-09-05	679,276	1,050	1,405,239	48.3%
2025-09-04	337,491	53	982,751	34.3%
2025-09-03	214,691	496	766,157	28.0%
2025-09-02	430,477	2,977	1,131,908	38.0%
2025-08-29	357,538	602	889,509	40.2%
2025-08-28	433,687	1,099	1,113,568	38.9%
2025-08-27	860,715	6,009	1,681,353	51.2%
2025-08-26	1,548,460	12,105	2,955,348	52.4%
2025-08-25	566,454	3,586	1,323,249	42.8%
2025-08-22	749,615	1,957	1,460,713	51.3%
2025-08-21	651,639	223	1,570,067	41.5%
2025-08-20	679,554	2,698	1,870,241	36.3%
2025-08-19	787,909	935	2,788,740	28.3%
2025-08-18	756,143	1,095	1,727,603	43.8%
2025-08-15	1,814,721	836	3,422,260	53.0%
2025-08-14	1,852,940	5,382	3,602,829	51.4%
2025-08-13	1,254,225	3,473	2,774,100	45.2%
2025-08-12	990,110	3,190	2,845,896	34.8%
2025-08-11	1,290,063	1,615	5,196,302	24.8%
2025-08-08	2,448,706	300,870	6,239,830	39.2%
2025-08-07	4,197,951	489,618	10,364,294	40.5%
2025-08-06	440,144	1,120	1,811,262	24.3%
2025-08-05	331,460	921	993,178	33.4%
2025-08-04	474,905	1,408	1,273,995	37.3%
2025-08-01	530,569	7,139	1,882,098	28.2%
2025-07-31	882,506	3,670	2,110,030	41.8%
2025-07-30	745,614	392	1,827,435	40.8%
2025-07-29	1,081,849	571	2,607,245	41.5%
2025-07-28	304,841	7,460	1,004,032	30.4%
2025-07-25	365,417	265	1,055,273	34.6%
2025-07-24	321,799	762	1,167,147	27.6%
2025-07-23	485,719	3,471	1,044,919	46.5%
2025-07-22	241,098	3,036	874,717	27.6%
2025-07-21	418,014	854	1,180,445	35.4%
2025-07-18	623,498	651	1,225,333	50.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CSPXx(MXN) CXE